Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extramedullary acute myelogenous leukemia
Melhem Solh, Scott R. Solomon, Lawrence E. Morris, et al.
Blood Reviews (2016) Vol. 30, Iss. 5, pp. 333-339
Closed Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved
Rory M. Shallis, Robert Peter Gale, Hillard M. Lazarus, et al.
Blood Reviews (2020) Vol. 47, pp. 100773-100773
Closed Access | Times Cited: 108
Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
Jan‐Niklas Eckardt, Friedrich Stölzel, Désirée Kunadt, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 37
Myeloid sarcoma
Omar Shahin, Farhad Ravandi
Current Opinion in Hematology (2020) Vol. 27, Iss. 2, pp. 88-94
Closed Access | Times Cited: 50
The Bone Marrow Microenvironment Mechanisms in Acute Myeloid Leukemia
Débora Bifano Pimenta, Vanessa Araújo Varela, Tarcila Santos Datoguia, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 40
C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse
Lixue Yang, Cheng-Tao Zhang, Meng‐Ying Yang, et al.
Blood (2022) Vol. 141, Iss. 7, pp. 766-786
Open Access | Times Cited: 25
Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey
Davide Lazzarotto, Anna Candoni, Carla Filì, et al.
Leukemia Research (2016) Vol. 53, pp. 74-81
Closed Access | Times Cited: 39
Clinical and molecular characteristics of extramedullary acute myeloid leukemias
Tariq Kewan, Waled Bahaj, Carmelo Gurnari, et al.
Leukemia (2024) Vol. 38, Iss. 9, pp. 2032-2036
Open Access | Times Cited: 4
Efficacy and safety of CAR-T therapy targeting CLL1 in patients with extramedullary diseases of acute myeloid leukemia
Yifan Zhao, Xue Bai, Shujing Guo, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Clinicopathological characteristics of de novo and secondary myeloid sarcoma: A monocentric retrospective study
Helena Claerhout, Sophie Van Aelst, C. Melis, et al.
European Journal Of Haematology (2018) Vol. 100, Iss. 6, pp. 603-612
Open Access | Times Cited: 36
Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial–mesenchymal transition pathways
Tiziana Ottone, Giorgia Silvestrini, Rocco Piazza, et al.
Leukemia (2023) Vol. 37, Iss. 12, pp. 2383-2394
Closed Access | Times Cited: 9
Genetic alterations in myeloid sarcoma among acute myeloid leukemia patients: insights from 37 cohort studies and a meta-analysis
Suvijak Untaaveesup, Sasinipa Trithiphen, Kamolchanok Kulchutisin, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Evidence for a role of decitabine in the treatment of myeloid sarcoma
Max Gornicec, Albert Wölfler, Susanne Stanzel, et al.
Annals of Hematology (2016) Vol. 96, Iss. 3, pp. 505-506
Closed Access | Times Cited: 21
The efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia with extramedullary involvement
Salman Otoukesh, Jianying Zhang, Ryotaro Nakamura, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2020) Vol. 61, Iss. 8, pp. 2020-2023
Closed Access | Times Cited: 19
Myeloid sarcoma: An overview
Maximiliano Ramia de, Weina Chen
Seminars in Diagnostic Pathology (2023) Vol. 40, Iss. 3, pp. 129-139
Closed Access | Times Cited: 7
Isolated myeloid sarcoma in the urinary bladder: A cases report
Ping Huang, Jian-Hui Xin, Xiaofeng Zou, et al.
Asian Journal of Surgery (2024) Vol. 47, Iss. 4, pp. 1928-1929
Open Access | Times Cited: 2
BATF promotes extramedullary infiltration through TGF‐β1/Smad/MMPs axis in acute myeloid leukemia
Ru Zhang, Jiyu Miao, Meng Zhai, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 6, pp. 1146-1159
Open Access | Times Cited: 2
Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges
Noemí Álvarez, Alejandro Martı́n, Sara Dorado, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Successful 5-azacytidine treatment of myeloid sarcoma and leukemia cutis associated with myelodysplastic syndrome
Takayuki Katagiri, Takashi Ushiki, Masayoshi Masuko, et al.
Medicine (2017) Vol. 96, Iss. 36, pp. e7975-e7975
Open Access | Times Cited: 20
Extra-medullary recurrence of myeloid leukemia as myeloid sarcoma after allogeneic stem cell transplantation: impact of conditioning intensity
Jochen J. Frietsch, Friederike Hunstig, Christoph Wittke, et al.
Bone Marrow Transplantation (2020) Vol. 56, Iss. 1, pp. 101-109
Open Access | Times Cited: 17
Extramedullary disease at diagnosis of AML does not influence outcome of patients undergoing allogeneic hematopoietic cell transplant in CR1
Christianne Bourlon, Jeffrey H. Lipton, Uday Deotare, et al.
European Journal Of Haematology (2017) Vol. 99, Iss. 3, pp. 234-239
Closed Access | Times Cited: 18
Successful treatment with gilteritinib for isolated extramedullary relapse of acute myeloid leukemia with FLT3-ITD mutation after allogeneic stem cell transplantation
Michiko Kida, Yoshiaki Kuroda, Miki Kido, et al.
International Journal of Hematology (2020) Vol. 112, Iss. 2, pp. 243-248
Closed Access | Times Cited: 16
Real-Time Molecular Monitoring in Acute Myeloid Leukemia With Circulating Tumor DNA
Deepshi Thakral, Ritu Gupta, Ranjit Kumar Sahoo, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 15
Isolated myelosarcoma is characterized by recurrent NFE2 mutations and concurrent preleukemic clones in the bone marrow
Vladimir Lazarević, Christina Orsmark‐Pietras, Henrik Lilljebjörn, et al.
Blood (2017) Vol. 131, Iss. 5, pp. 577-581
Open Access | Times Cited: 16
Long-Lasting Remission in De Novo Breast Myeloid Sarcoma Treated with Decitabine and Radiotherapy
Carla Minoia, V. Fazio, Giovanni Scognamillo, et al.
Diagnostics (2019) Vol. 9, Iss. 3, pp. 84-84
Open Access | Times Cited: 13
Clinical characteristics, treatment options, and prognosis of myeloid sarcoma: analysis using the SEER database
Jingjing Liang, Liu Yang, Bo Yang, et al.
Hematology (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top